JPH0791173B2 - Liposomes containing skin cosmetics - Google Patents
Liposomes containing skin cosmeticsInfo
- Publication number
- JPH0791173B2 JPH0791173B2 JP61194747A JP19474786A JPH0791173B2 JP H0791173 B2 JPH0791173 B2 JP H0791173B2 JP 61194747 A JP61194747 A JP 61194747A JP 19474786 A JP19474786 A JP 19474786A JP H0791173 B2 JPH0791173 B2 JP H0791173B2
- Authority
- JP
- Japan
- Prior art keywords
- hydrogenated
- liposome
- component
- present
- containing skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000002502 liposome Substances 0.000 title claims description 36
- 239000002537 cosmetic Substances 0.000 title claims description 26
- 229930195733 hydrocarbon Natural products 0.000 claims description 19
- 150000002430 hydrocarbons Chemical class 0.000 claims description 19
- 239000007788 liquid Substances 0.000 claims description 19
- 239000004215 Carbon black (E152) Substances 0.000 claims description 16
- 239000012528 membrane Substances 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 238000002156 mixing Methods 0.000 claims description 10
- 239000000126 substance Substances 0.000 claims description 10
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims description 6
- 229940099578 hydrogenated soybean lecithin Drugs 0.000 claims description 5
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical class CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 claims description 4
- 150000008106 phosphatidylserines Chemical class 0.000 claims description 4
- 239000008350 hydrogenated phosphatidyl choline Substances 0.000 claims description 3
- 150000008105 phosphatidylcholines Chemical class 0.000 claims description 3
- 150000003904 phospholipids Chemical class 0.000 description 16
- 239000000203 mixture Substances 0.000 description 11
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 230000003020 moisturizing effect Effects 0.000 description 6
- 238000002834 transmittance Methods 0.000 description 6
- 238000004220 aggregation Methods 0.000 description 5
- 230000002776 aggregation Effects 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- 238000001556 precipitation Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 4
- 229940032094 squalane Drugs 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 239000003012 bilayer membrane Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940042880 natural phospholipid Drugs 0.000 description 3
- -1 pH adjusters Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000001953 sensory effect Effects 0.000 description 3
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 239000003094 microcapsule Substances 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FQCSIUSICFAMDD-UHFFFAOYSA-N 2-oxopyrrolidine-1-carboxylic acid;sodium Chemical compound [Na].OC(=O)N1CCCC1=O FQCSIUSICFAMDD-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920001083 polybutene Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 229940083466 soybean lecithin Drugs 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Cosmetics (AREA)
Description
【発明の詳細な説明】 [産業上の利用分野] 本発明は新規なリポソーム含有皮膚化粧料に関し、さら
に詳しくは、膜成分物質が特定の水素添加リン脂質と液
状炭化水素とからなり、かつこれら2成分と水とを特定
の比率で配合することを特徴とする、経時安定性が良好
であって、しかも使用感が非常に優れたリポソーム含有
皮膚化粧料に関するものである。TECHNICAL FIELD The present invention relates to a novel liposome-containing skin cosmetic, and more specifically, the membrane component substance is composed of a specific hydrogenated phospholipid and a liquid hydrocarbon, and The present invention relates to a liposome-containing skin cosmetic which is characterized by mixing two components and water in a specific ratio, has good stability over time, and has an extremely excellent feeling in use.
[従来の技術] リポソームは、生体膜の主要構成成分であるリン脂質の
二分子膜からなる閉鎖小胞であり、生体膜モデルとして
研究に用いられると共に、古くから薬剤のマイクロカプ
セルとして医薬品や化粧品への利用が試みられてきた
(特開昭49−118826号,特開昭52−6375号公報)。特に
化粧料分野においては、リポソームはマイクロカプセル
として価値のある形態であると共に、その構成成分であ
るリン脂質そのものが生体膜由来の安全性の高い両親媒
性物質であり、保湿効果も有することから、注目を集め
てきた。[Prior Art] Liposomes are closed vesicles composed of bilayer membranes of phospholipids, which are the main constituents of biological membranes, and have been used for research as a biological membrane model, and have long been used as microcapsules of pharmaceuticals and cosmetics. It has been attempted to be used for such purposes (Japanese Patent Laid-Open Nos. 49-118826 and 52-6375). Particularly in the field of cosmetics, liposome is a valuable form as a microcapsule, and its constituent component, phospholipid itself, is a highly safe amphipathic substance derived from biological membrane, and also has a moisturizing effect. , Has been attracting attention.
しかしながら、天然のリン脂質を用いたリポソームで
は、不飽和脂肪酸を多く含んでいるために酸化等の化学
的変化によって膜構造が弱くなる他、物理的な変化によ
っても膜が破壊され、保持物質が漏出しやすいという欠
点があった。また、酸化による変色・変臭等の問題もあ
った。However, since liposomes using natural phospholipids contain a large amount of unsaturated fatty acids, the membrane structure is weakened due to chemical changes such as oxidation, and the membrane is destroyed due to physical changes, resulting in retention of substances. There was a drawback that it was easy to leak. There is also a problem of discoloration and odor due to oxidation.
このように、天然のリン脂質では脂質の酸化が生じやす
いため、酸化防止を目的として、二分子膜中にα−トコ
フェロール等の酸化防止剤を添加する方法や、合成リン
脂質・水素添加リン脂質を利用する方法がとられてき
た。As described above, since natural phospholipids tend to oxidize lipids, a method of adding an antioxidant such as α-tocopherol to the bilayer membrane for the purpose of antioxidant, or a synthetic phospholipid / hydrogenated phospholipid Has been taken.
一方、膜を安定化して薬剤の漏出を防止する手段とし
て、生体膜において膜の安定化に寄与しているコレステ
ロールを利用することが知られている他、親水性高分子
や油性物質を添加する試みがなされている。また、リポ
ソームとして一方安定なものを得るために、天然のリン
脂質よりも相転移温度(Tc)が高い合成リン脂質や水素
添加リン脂質を用いることも知られている。On the other hand, it is known to utilize cholesterol, which contributes to the stabilization of the membrane in the biological membrane, as a means for stabilizing the membrane and preventing the leakage of the drug, and adding a hydrophilic polymer or an oily substance. Attempts are being made. It is also known to use synthetic phospholipids or hydrogenated phospholipids having a higher phase transition temperature (Tc) than natural phospholipids in order to obtain liposomes that are stable on the one hand.
[発明が解決しようとする問題点] 上記の如く、従来、リポソームを医薬品や化粧品に利用
すべく種々検討されてきた。[Problems to be Solved by the Invention] As described above, various studies have hitherto been made to utilize liposomes for pharmaceuticals and cosmetics.
しかしながら、化粧品として利用する場合、他の化粧品
原料を添加すると凝集や沈殿が生じたり、リポソームが
形成しなかったりして、リポソームを安定に配合するこ
とは困難であり、また、単にリポソームを配合しただけ
では使用感等の官能的な効果が十分でなく、未だ満足す
べきものが得られていないのが実情であった。However, when used as a cosmetic product, it is difficult to stably mix liposomes because addition or addition of other cosmetic raw materials causes aggregation or precipitation, or liposomes are not formed. However, the sensual effect such as feeling of use is not sufficient by itself, and the actual situation is that a satisfactory result has not been obtained yet.
[問題点を解決するための手段] 本発明者らは、係る点に鑑み、リポソームの安定性を損
うことなく、使用感の優れたリポソーム含有皮膚化粧料
を得るべく鋭意研究した結果、膜成分物質として特定の
水素添加リン脂質に対して組成比が1:1以下となるよう
に液状炭化水素を添加し、かつこれら2成分と水とを特
定の比率で配合することにより、非常に優れた使用感を
有するリポソーム含有皮膚化粧料が得られることを見出
し、本発明を完成するに至った。[Means for Solving Problems] In view of the above points, the present inventors have earnestly studied in order to obtain a liposome-containing skin cosmetic having an excellent feeling of use without impairing the stability of the liposome, and as a result, a film By adding liquid hydrocarbon as a component substance to a specific hydrogenated phospholipid so that the composition ratio is 1: 1 or less, and mixing these two components and water in a specific ratio, it is very excellent It was found that a liposome-containing skin cosmetic having a feeling of use can be obtained, and the present invention has been completed.
すなわち、本発明は、膜成分物質が(A)水素添加大豆
レシチン、水素添加卵黄レシチン、水素添加ホスファチ
ジルコリン、水素添加ホルファチジルセリンから選ばれ
る1種もしくは2種以上と、(B)液状炭化水素からな
り、かつ(B)成分の(A)成分に対する比率が重量比
で1:1以下であり、これら2成分と(C)水との配合比
率が重量比で(A)成分:(B)成分:(C)成分=0.
1〜9.5:0.01〜1.5:90.5〜99.89であることを特徴とする
リポソーム含有皮膚化粧料である。That is, in the present invention, the membrane component substance is (A) one or more selected from hydrogenated soybean lecithin, hydrogenated egg yolk lecithin, hydrogenated phosphatidylcholine and hydrogenated phosphatidylserine, and (B) a liquid hydrocarbon. And the ratio of the component (B) to the component (A) is 1: 1 or less by weight, and the mixing ratio of these two components and water (C) is (A) component: (B). Component: (C) component = 0.
The liposome-containing skin cosmetic is characterized in that it is 1 to 9.5: 0.01 to 1.5: 90.5 to 99.89.
本発明に係るリポソーム含有皮膚化粧料における特定の
水素添加リン脂質としては、ヨウ素価が30以下のものが
好ましく、天然レシチンである大豆レシチン、卵黄レシ
チンを常法に従って水素添加したものの他、ホスファチ
ジルコリン、ホスファチジルセリンを水素添加したもの
が挙げられ、これらから選ばれる1種もしくは2種以上
が用い得る。As the specific hydrogenated phospholipid in the liposome-containing skin cosmetics according to the present invention, iodine value is preferably 30 or less, soybean lecithin which is natural lecithin, other than those hydrogenated egg yolk lecithin according to a conventional method, phosphatidylcholine, Examples thereof include hydrogenated phosphatidylserine, and one or more selected from these may be used.
また、本発明に必須に使用される液状炭化水素は、常温
で液状のものであって、通常化粧品用原料として使われ
るものであれば良く、例えばスクワラン、プリスタン、
流動パラフィン、低粘度ポリブテン(粘度5〜1000cs
t)等が挙げられる。これらは必要に応じて任意に選択
し、単独若しくは併用して用いられる。液状炭化水素の
特定の水素添加リン脂質に対する比率は、重量比で1:1
以下である。液状炭化水素の量が特定の水素添加リン脂
質より多くなるとリポソームの二分子膜の形成が難し
く、沈殿や凝集が生じるようになる。Further, the liquid hydrocarbon essential to the present invention may be a liquid hydrocarbon at room temperature, which is usually used as a raw material for cosmetics, for example, squalane, pristane,
Liquid paraffin, low viscosity polybutene (viscosity 5-1000cs
t) and the like. These are arbitrarily selected according to need and used alone or in combination. The ratio of liquid hydrocarbons to specific hydrogenated phospholipids is 1: 1 by weight.
It is the following. When the amount of the liquid hydrocarbon is larger than that of the specific hydrogenated phospholipid, it is difficult to form the bilayer membrane of the liposome, and the precipitation or aggregation occurs.
本発明のリポソーム含有皮膚化粧料は、上記の如く膜成
分物質が(A)水素添加大豆レシチン、水素添加卵黄レ
シチン、水素添加ホスファチジルコリン、水素添加ホル
ファチジルセリンから選ばれる1種もしくは2種以上
と、(B)液状炭化水素からなるものがあるが、リポソ
ームが安定に存在するためには、これら2成分と(C)
水との配合比率は、種々検討を重ねた結果、重量比で
(A)成分:(B)成分:(C)成分=0.1〜9.5:0.01
〜1.5:90.5〜99.89であることが好ましい。第1図に、
安定に存在する為に好ましい配合比を示す3成分の三角
座標を示す。斜線で示す好ましい領域においては、常法
により、保持率を測定することによって、リポソームが
生成し、安定性も良好であることが確認されている。上
記範囲より特定の水素添加リン脂質及び液状炭化水素の
量が多くなると、リポソームの安定性が悪くなり、沈殿
・凝集・分離等を生じやすい。特定の水素添加リン脂質
の量が上記範囲より少ない場合には、リン脂質の有する
保湿効果等の効果が得られない。また、液状炭化水素を
配合しない場合には、リポソームは得られるものの、化
粧品的な効果は少なくなる。すなわち、液状炭化水素の
量が上記範囲より少ない場合には、エモリエント効果が
なく、本発明の目的を達成する上で好ましくない。In the liposome-containing skin cosmetic of the present invention, as described above, the membrane component substance is one or more selected from (A) hydrogenated soybean lecithin, hydrogenated egg yolk lecithin, hydrogenated phosphatidylcholine, and hydrogenated phosphatidylserine. , (B) are composed of liquid hydrocarbon, but in order for liposome to exist stably, these two components and (C)
As a result of various investigations, the blending ratio with water was, by weight ratio, (A) component: (B) component: (C) component = 0.1 to 9.5: 0.01.
It is preferable that it is -1.5: 90.5-99.89. In Figure 1,
Triangular coordinates of three components showing preferable compounding ratios for stable existence are shown. It has been confirmed that, in a preferable region indicated by a diagonal line, liposomes are formed and stability is good by measuring the retention rate by a conventional method. If the amount of the specific hydrogenated phospholipid and the liquid hydrocarbon exceeds the above range, the stability of the liposome is deteriorated and precipitation, aggregation, separation, etc. are likely to occur. When the amount of the specific hydrogenated phospholipid is less than the above range, the moisturizing effect and the like of the phospholipid cannot be obtained. Further, when the liquid hydrocarbon is not added, liposomes are obtained, but the cosmetic effect is reduced. That is, when the amount of the liquid hydrocarbon is less than the above range, there is no emollient effect, which is not preferable in achieving the object of the present invention.
通常リポソームを調製するのに用いられる方法として
は、 i)脂質溶液より有機溶媒を除き調製された脂質フィル
ムに水を加えて分散させる方法 ii)脂質溶液を水中に注入した後に有機溶媒を除く方法 iii)脂質を水中に単に分散させる方法 等が挙げられるが、本発明のリポソームを得るに際して
は、上記の一般的な方法のいずれでも良く、特に限定さ
れない。The methods usually used for preparing liposomes are: i) removing the organic solvent from the lipid solution and adding water to the prepared lipid film to disperse it. Ii) injecting the lipid solution into water and then removing the organic solvent. iii) A method of simply dispersing a lipid in water and the like can be mentioned, but in obtaining the liposome of the present invention, any of the above-mentioned general methods may be used without any particular limitation.
本発明のリポソーム含有皮膚化粧料は上記必須成分から
なり、透明〜半透明の外観を有するものである。通常、
液状炭化水素を水系に安定に配合する妙には多量の界面
活性剤を用いて可溶化するか、液状炭化水素が多量の場
合には乳化させる必要があるが、界面活性剤を用いた場
合にはリポソームをこわしてしまう。しかし、本発明に
より、リポソームの形態を損うことなく、液状炭化水素
を安定に水系に配合することが可能となったのである。The liposome-containing skin cosmetic of the present invention is composed of the above essential components and has a transparent to translucent appearance. Normal,
It is necessary to solubilize liquid hydrocarbons stably in an aqueous system by using a large amount of surfactant, or to emulsify when liquid hydrocarbons are large, but when using a surfactant Breaks the liposomes. However, according to the present invention, it has become possible to stably add a liquid hydrocarbon to an aqueous system without impairing the morphology of the liposome.
さらに、本発明のリポソーム含有皮膚化粧料には、上記
必須成分以外に通常化粧料に使用される保湿剤、紫外線
吸収剤、アルコール類、キレート剤、pH調整剤、防腐
剤、増粘剤、色素、香料等を、本発明の目的を妨げない
範囲で適宜配合し得る。Furthermore, in the liposome-containing skin cosmetic of the present invention, in addition to the above essential components, moisturizers, ultraviolet absorbers, alcohols, chelating agents, pH adjusters, preservatives, thickeners, pigments that are usually used in cosmetics. , A fragrance, etc. may be appropriately blended within a range not impairing the object of the present invention.
[実施例] 次に、本発明について、実施例を挙げてさらに説明す
る。これらは本発明を何ら限定するものではない。EXAMPLES Next, the present invention will be further described with reference to examples. These do not limit the invention in any way.
実施例[1] まず、表1に処方を示す〜の9種の試料を調製し、
透過率の測定及び外観の観察により、経時安定性につい
て検討した。表中、配合量は重量部である。結果を表2
に示す。Example [1] First, 9 kinds of samples whose formulations are shown in Table 1 were prepared,
The temporal stability was examined by measuring the transmittance and observing the appearance. In the table, the blending amount is parts by weight. The results are shown in Table 2.
Shown in.
(製法) A (1)〜(3)、及び(5)〜(13)から選ばれる
1種をそれぞれ85℃に加熱、混合溶解する。 (Manufacturing Method) A One kind selected from (1) to (3) and (5) to (13) is heated to 85 ° C. and mixed and dissolved.
B Aに(4)を徐々に添加しながら撹拌混合する。Stir and mix while slowly adding (4) to BA.
C Bを室温まで冷却する。Cool CB to room temperature.
(透過率の測定) 試料調製直後及び1週間室温放置後の透過率を(株)島
津製作所製分光光度UV−160により測定した。測定条件
は700nmで行った。 (Measurement of Transmittance) Transmittance was measured by spectrophotometric UV-160 manufactured by Shimadzu Corporation immediately after the sample preparation and after being left at room temperature for 1 week. The measurement condition was 700 nm.
(外観) 試料調製1週間後の状態を観察した。(Appearance) The state after one week of sample preparation was observed.
○……変化なく良好 ×……沈殿・凝集が生じている 表2の結果から明らかな如く、液状炭化水素を配合した
試料〜のリポソーム含有皮膚化粧料(本発明品)
は、調製直後及び1週間後の透過率が高く、透明〜半透
明の均一な外観を呈しており、通常リポソームの膜を安
定化することで知られているコレステロールと同等、ま
たはそれ以上に経時安定性の良好なものであった。一方
炭化水素油以外の液状油を配合した試料〜(比較
品)では、透過率が非常に低い白濁状態であり、また経
時的にクリーミング・沈殿・凝集等が生じ、安定なもの
は得られなかった。◯: Good without change ×: Precipitation / aggregation occurred As is clear from the results in Table 2, the liposome-containing skin cosmetics of the samples containing the liquid hydrocarbon (the present invention).
Has a high transmittance immediately after preparation and after 1 week, and has a transparent to translucent uniform appearance, and has a aging equivalent to or higher than that of cholesterol, which is generally known to stabilize the liposome membrane. The stability was good. On the other hand, samples containing liquid oils other than hydrocarbon oils (comparative products) were in a cloudy state with extremely low transmittance, and creaming, precipitation, aggregation, etc. occurred over time, and stable products could not be obtained. It was
実施例[2] 表3に処方を示す13種の試料を調製し、前述と同様の方
法で経時安定性について検討した。Example [2] Thirteen kinds of samples whose formulations are shown in Table 3 were prepared, and stability with time was examined by the same method as described above.
表中、配合量は重量部である。結果を表3に示す。In the table, the blending amount is parts by weight. The results are shown in Table 3.
(製法) A (1)〜(2)及び(4)〜(5)をそれぞれ85℃
に加熱、混合溶解する。 (Manufacturing method) A (1) to (2) and (4) to (5) are each 85 ° C.
Heat to mix and dissolve.
B Aに(3)を徐々に添加しながら撹拌混合する。Stir and mix while slowly adding (3) to BA.
C Bを室温まで冷却する。Cool CB to room temperature.
表3に示す如く、水素添加大豆レシチン、スクワラン、
水の配合比率を変えて検討した結果、これら3成分の比
率が第1図の斜線で示す領域内にある場合にのみ、高い
透過率が得られ、また経時安定性も良好なものであっ
た。As shown in Table 3, hydrogenated soybean lecithin, squalane,
As a result of investigating by changing the mixing ratio of water, high transmittance was obtained and stability over time was good only when the ratio of these three components was within the shaded region in FIG. .
次に、本発明の官能的効果を確認するために、実施例
[2]の試料(本発明品)及び後に処方を示す本発明
品と同様な透明の形態を有する従来の皮膚化粧料である
比較品を用いて、女性10名からなるパネルを対象として
使用テストを行った。使用テストは官能評価によって行
い、表4に示す4種の項目につき、各々5段階評価とし
た。尚、評価結果は各パネルの評価点の平均を示す。Next, in order to confirm the sensory effect of the present invention, a conventional skin cosmetic having a transparent form similar to that of the sample of the present invention (product of the present invention) and the product of the present invention whose formulation is shown later. Using the comparative product, a use test was conducted on a panel of 10 women. The use test was conducted by sensory evaluation, and each of the four items shown in Table 4 was evaluated by 5 grades. The evaluation results are the average of the evaluation points of each panel.
比較品 (処方) (重量%) (1) スクワラン 0.01 (2) ポリオキシエチレンモノオレイン酸 ソルビタン(20E.O.) 0.5 (3) ポリオキシエチレン硬化ヒマシ油 0.5 (4) エチルアルコール 5.0 (5) 1,3−ブチレングリコール 15.0 (6) グリセリン 5.0 (7) アルギン酸ナトリウム 10.0 (1%水溶液) (8) カルボキシメチルセルロース 10.0 (1%水溶液) (9) 精製水 残量 (製法) A (1)〜(4)を混合溶解する。Comparative product (Formulation) (% by weight) (1) Squalane 0.01 (2) Polyoxyethylene monooleate sorbitan (20E.O.) 0.5 (3) Polyoxyethylene hydrogenated castor oil 0.5 (4) Ethyl alcohol 5.0 (5) 1,3-Butylene glycol 15.0 (6) Glycerin 5.0 (7) Sodium alginate 10.0 (1% aqueous solution) (8) Carboxymethylcellulose 10.0 (1% aqueous solution) (9) Purified water residual amount (production method) A (1) to ( 4) is mixed and dissolved.
B (5)〜(9)を混合溶解する。B (5) to (9) are mixed and dissolved.
C AとBを撹拌混合する。Stir mix CA and B.
表4の結果から明らかな如く、試料のリポソーム含有
皮膚化粧料(本発明品)は、比較品と比較して、使用時
にのび、肌へのなじみが良く、しかもまろやかでありな
がらさっぱり感を有し、使用後にしっとり感が残り、翌
日まで潤い感の持続する優れた使用感を有するものであ
った。 As is clear from the results in Table 4, the sample liposome-containing skin cosmetics (product of the present invention), when compared with the comparative product, spreads better at the time of use, was more familiar to the skin, and had a mellow yet refreshing feeling. However, it had an excellent feeling of use that remained moist after use and remained moist until the next day.
更に本発明に係るリポソーム含有皮膚化粧料の官能的効
果を確認するために、試料を用いて広範囲にわたる使
用テストを行った。使用テストは141名の女子パネルに
よる官能検査によって行い、表5に示す8種の項目につ
き、5段階評価とした。表5に評価結果を示す。尚、表
中の値は、各ランクに評価した人数を示す。Further, in order to confirm the organoleptic effect of the liposome-containing skin cosmetic according to the present invention, a wide range of use tests were conducted using the samples. The usage test was conducted by a sensory test by a panel of 141 females, and the eight items shown in Table 5 were evaluated on a 5-point scale. Table 5 shows the evaluation results. The values in the table indicate the number of people evaluated in each rank.
表5の結果から明らかな如く、本発明のリポソーム含有
皮膚化粧料は、経時安定性が良好なだけでなく、使用時
においてはのびや肌へのなじみが良く、べとつき感もな
く、使用後にはしっとり感、潤った感じが残り、しかも
効果が持続する、使用感の非常に優れたものであった。 As is clear from the results in Table 5, the liposome-containing skin cosmetic composition of the present invention has not only good stability over time, but also good spreadability and familiarity to the skin during use, no sticky feeling, and a good feeling after use. The moist feeling and moisturizing feeling remained, and the effect was long lasting, and the feeling of use was very excellent.
実施例[3]栄養化粧水 (処方) (重量%) (1) 水素添加大豆レシチン 1.5 (2) スクワラン 0.2 (3) グリセリン 5.0 (4) 1,3−ブチレングリコール 15.0 (5) メチルパラベン 0.1 (6) ピロリドンカルボン酸 0.01 (7) ピロリドンカルボン酸ナトリウム 0.1 (8) コラーゲン加水分解物 0.01 (9) 香料 0.01 (10) 精製水 残量 (製法) A (1)〜(5)、(9)を85℃に加熱して混合溶解
する。Example [3] Nutritional lotion (prescription) (% by weight) (1) Hydrogenated soybean lecithin 1.5 (2) Squalane 0.2 (3) Glycerin 5.0 (4) 1,3-butylene glycol 15.0 (5) Methylparaben 0.1 (6) ) Pyrrolidone carboxylic acid 0.01 (7) Sodium pyrrolidone carboxylic acid 0.1 (8) Collagen hydrolyzate 0.01 (9) Perfume 0.01 (10) Purified water residual amount (production method) A (1) to (5), (9) Heat to ℃ to mix and dissolve.
B (6)〜(8)を(10)に溶解する。B (6) to (8) are dissolved in (10).
C BをAに徐々に添加しながら撹拌混合する。Stir mix while gradually adding CB to A.
D Cを室温まで冷却する。Allow DC to cool to room temperature.
上記の如くして製造した実施例[3]の栄養化粧水は、
経時安定性が良好なだけでなく、のびや肌へのなじみが
良く、しっとりとした使用感を有するものであった。The nutritional lotion of Example [3] produced as described above is
Not only the stability over time was good, but also the spreadability and the familiarity with the skin were good, and the product had a moisturizing feeling.
[発明の効果] 以上詳述した如く、本発明は、膜成分物質が特定の水素
添加リン脂質と液状炭化水素とからなり、かつこれら2
成分と水と特定の比率で配合することにより、従来にな
い顕著な効果を発現せしめたものである。[Effects of the Invention] As described in detail above, in the present invention, the membrane component substance is composed of a specific hydrogenated phospholipid and liquid hydrocarbon, and these 2
By mixing the components and water in a specific ratio, a remarkable effect which has never been obtained is exhibited.
すなわち、本発明により、リポソームを安定に配合しな
がら、透明〜半透明の良好な外観を有し、しかもしっと
り感・潤い感の極めて優れた新規なリポソーム含有皮膚
化粧料を提供することが可能となったのである。That is, according to the present invention, it is possible to provide a novel liposome-containing skin cosmetic which has a good appearance of transparent to translucent and is extremely excellent in moisturizing and moisturizing feeling while stably blending liposomes. It has become.
第1図は、本発明に係るリポソーム含有皮膚化粧料が安
定に存在する為に好ましい(A)特定の水素添加リン脂
質、(B)液状炭化水素、(C)水の3成分の配合比を
示す図面である。FIG. 1 shows the compounding ratio of the three components (A) a specific hydrogenated phospholipid, (B) a liquid hydrocarbon, and (C) water, which is preferable for the stable presence of the liposome-containing skin cosmetic according to the present invention. It is a drawing shown.
Claims (1)
ン、水素添加卵黄レシチン、水素添加ホスファチジルコ
リン、水素添加ホスファチジルセリンから選ばれる1種
もしくは2種以上と、(B)液状炭化水素からなり、か
つ(B)成分の(A)成分に対する比率が重量比で1:1
以下であり、これら2成分と(C)水との配合比率が重
量比で(A)成分:(B)成分:(C)成分=0.1〜9.
5:0.01〜1.5:90.5〜99.89であることを特徴とするリポ
ソーム含有皮膚化粧料。1. A membrane component substance comprising (A) one or more selected from hydrogenated soybean lecithin, hydrogenated egg yolk lecithin, hydrogenated phosphatidylcholine and hydrogenated phosphatidylserine, and (B) a liquid hydrocarbon, And the ratio of component (B) to component (A) is 1: 1 by weight.
The following are the mixing ratios of these two components and (C) water in terms of weight ratio: (A) component: (B) component: (C) component = 0.1 to 9.
A liposome-containing skin cosmetic, which is 5: 0.01 to 1.5: 90.5 to 99.89.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP61194747A JPH0791173B2 (en) | 1986-08-20 | 1986-08-20 | Liposomes containing skin cosmetics |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP61194747A JPH0791173B2 (en) | 1986-08-20 | 1986-08-20 | Liposomes containing skin cosmetics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6351311A JPS6351311A (en) | 1988-03-04 |
| JPH0791173B2 true JPH0791173B2 (en) | 1995-10-04 |
Family
ID=16329555
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP61194747A Expired - Lifetime JPH0791173B2 (en) | 1986-08-20 | 1986-08-20 | Liposomes containing skin cosmetics |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0791173B2 (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0773245A (en) * | 1993-06-21 | 1995-03-17 | Nec Corp | Parking lot managing device |
| CA2181699A1 (en) * | 1994-01-19 | 1995-07-27 | Takako Fujii | Dermatologic composition |
| JP4938331B2 (en) * | 2006-03-31 | 2012-05-23 | 株式会社コーセー | Emulsified cosmetic |
| JP2008094809A (en) * | 2006-10-16 | 2008-04-24 | Kose Corp | Liposome composition and cosmetic compounded with the same, and external preparation for skin |
| WO2009013864A1 (en) * | 2007-07-20 | 2009-01-29 | Kose Corporation | Vesicle composition and external preparation for skin |
| JP5881139B2 (en) * | 2011-03-28 | 2016-03-09 | 株式会社 資生堂 | Liquid composition and transparent or translucent aqueous composition using the same |
| JP6471407B2 (en) * | 2013-12-25 | 2019-02-20 | サンスター株式会社 | Oral or throat composition |
| JP6440954B2 (en) * | 2014-03-18 | 2018-12-19 | サンスター株式会社 | Oral care composition |
| JP6486601B2 (en) * | 2014-03-28 | 2019-03-20 | サンスター株式会社 | Oral care composition |
| JP6036879B2 (en) * | 2015-03-04 | 2016-11-30 | 栗田工業株式会社 | Selective permeable membrane for water treatment and method for producing the same |
| JP6580735B2 (en) * | 2018-03-16 | 2019-09-25 | サンスター株式会社 | Oral care composition |
| JP7735617B2 (en) * | 2021-05-18 | 2025-09-09 | 株式会社ファンケル | Liposome dispersion, and cosmetics and topical skin preparations containing liposome dispersion |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58201708A (en) * | 1982-05-18 | 1983-11-24 | Asahi Chem Ind Co Ltd | Cosmetic composition |
| JPS5910511A (en) * | 1982-07-07 | 1984-01-20 | Eisai Co Ltd | Aqueous solution containing fat-soluble substance |
| JPS60166368A (en) * | 1984-02-09 | 1985-08-29 | Kawaken Fine Chem Co Ltd | Thickening and gelling agent |
| JPH06690B2 (en) * | 1985-02-09 | 1994-01-05 | 鐘紡株式会社 | Soluble water-based transparent cosmetic |
-
1986
- 1986-08-20 JP JP61194747A patent/JPH0791173B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6351311A (en) | 1988-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4767625A (en) | Lamella type single phase liquid crystal composition and oil-base cosmetic compositions using the same | |
| DE69900264T3 (en) | Nanoemulsion of ethoxylated fatty alcohol ethers or ethoxylated fatty acid esters and their uses in cosmetics, dermatology and / or ophthalmology | |
| KR100439068B1 (en) | Stablized cosmetic material containing triple layered retonol | |
| KR101052493B1 (en) | Blessicle dispersions and cosmetics containing the same | |
| US20100080833A1 (en) | Stable, concentrated and dilute, oil-in-water emulsions, their processes of preparation, and formulation process employing these emulsions | |
| JPH0791173B2 (en) | Liposomes containing skin cosmetics | |
| JP4049216B2 (en) | Formulation with liquid crystal structure | |
| CN109414390B (en) | External preparation for skin | |
| EP0863192B1 (en) | Humectant composition, base containing the same, and cosmetic material or external preparation containing said humectant composition | |
| KR101572216B1 (en) | Solubilized formulation containing micelle of intercellular lipid ingredients | |
| JPH08259433A (en) | Cosmetic or preparation for external use containing humectant composition | |
| JP3521517B2 (en) | External preparation for skin | |
| JP5000033B2 (en) | Advanced hydrogenated lecithin | |
| PT877595E (en) | COMPOSITION DERMOCOSMETICS RETINAL CONTAINING | |
| JPH022850B2 (en) | ||
| JPS61204109A (en) | Emulsion-type composition for external use | |
| JP2678138B2 (en) | O / W emulsion cosmetic composition containing milk | |
| JPH02223506A (en) | Cosmetic containing liquid crystal | |
| KR0133836B1 (en) | Cosmetic composition of the multi-emulsification type containing microspheres of beta glucan and its preparation method | |
| JPH0349886B2 (en) | ||
| JPH0525030A (en) | Skin cosmetic | |
| CN115501123A (en) | Stable double-layer toning lotion and preparation method thereof | |
| JPS63154606A (en) | Transparent skin cosmetic | |
| KR100439595B1 (en) | Tocopherol-containing Ceramide Liquid Crystal Capsule, Emulsion thereof and Cosmetic comprising the same | |
| JPH02200607A (en) | Cosmetic |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |